{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:38:07Z","timestamp":1792694287636,"version":"4.5.0"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"20","funder":[{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","award":["20130751"],"award-info":[{"award-number":["20130751"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","award":["20160852"],"award-info":[{"award-number":["20160852"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","award":["2015.0296"],"award-info":[{"award-number":["2015.0296"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["CAN2014-424"],"award-info":[{"award-number":["CAN2014-424"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["621-2014-5629"],"award-info":[{"award-number":["621-2014-5629"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"publisher","award":["160502"],"award-info":[{"award-number":["160502"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002002","name":"Cancer Research Foundation","doi-asserted-by":"publisher","award":["161052"],"award-info":[{"award-number":["161052"]}],"id":[{"id":"10.13039\/100002002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["6844391"],"award-info":[{"award-number":["6844391"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009734","name":"Alex and Eva Wallstr\u00f6m Foundation","doi-asserted-by":"publisher","award":["2018-00222"],"award-info":[{"award-number":["2018-00222"]}],"id":[{"id":"10.13039\/501100009734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"KI","doi-asserted-by":"publisher","award":["2016fobi50190"],"award-info":[{"award-number":["2016fobi50190"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cutaneous malignant melanoma (melanoma) is characterized by a high mutational load, extensive intertumoral and intratumoral genetic heterogeneity, and complex tumor microenvironment (TME) interactions. Further insights into the mechanisms underlying melanoma are crucial for understanding tumor progression and responses to treatment. Here we adapted the technology of spatial transcriptomics (ST) to melanoma lymph node biopsies and successfully sequenced the transcriptomes of over 2,200 tissue domains. Deconvolution combined with traditional approaches for dimensional reduction of transcriptome-wide data enabled us to both visualize the transcriptional landscape within the tissue and identify gene expression profiles linked to specific histologic entities. Our unsupervised analysis revealed a complex spatial intratumoral composition of melanoma metastases that was not evident through morphologic annotation. Each biopsy showed distinct gene expression profiles and included examples of the coexistence of multiple melanoma signatures within a single tumor region as well as shared profiles for lymphoid tissue characterized according to their spatial location and gene expression profiles. The lymphoid area in close proximity to the tumor region displayed a specific expression pattern, which may reflect the TME, a key component to fully understanding tumor progression. In conclusion, using the ST technology to generate gene expression profiles reveals a detailed landscape of melanoma metastases. This should inspire researchers to integrate spatial information into analyses aiming to identify the factors underlying tumor progression and therapy outcome.<\/jats:p>\n               <jats:p>Significance: Applying ST technology to gene expression profiling in melanoma lymph node metastases reveals a complex transcriptional landscape in a spatial context, which is essential for understanding the multiple components of tumor progression and therapy outcome. Cancer Res; 78(20); 5970\u20139. \u00a92018 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-18-0747","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T17:04:21Z","timestamp":1535475861000},"page":"5970-5979","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":358,"title":["Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma"],"prefix":"10.1158","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3109-5551","authenticated-orcid":false,"given":"Kim","family":"Thrane","sequence":"first","affiliation":[{"name":"1Department of Gene Technology, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Eriksson","sequence":"additional","affiliation":[{"name":"2Department of Oncology-Pathology, Karolinska Institutet, SE-17176 Stockholm, Sweden."},{"name":"3Department of Oncology, Karolinska University Hospital, SE-17176 Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Maaskola","sequence":"additional","affiliation":[{"name":"1Department of Gene Technology, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Hansson","sequence":"additional","affiliation":[{"name":"2Department of Oncology-Pathology, Karolinska Institutet, SE-17176 Stockholm, Sweden."},{"name":"3Department of Oncology, Karolinska University Hospital, SE-17176 Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Lundeberg","sequence":"additional","affiliation":[{"name":"1Department of Gene Technology, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"2022061706035193600_bib1","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1200\/JCO.2002.06.140","article-title":"Influence of unrecognized molecular heterogeneity on randomized clinical trials","volume":"20","author":"Betensky","year":"2002","journal-title":"J Clin Oncol"},{"key":"2022061706035193600_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature12624","article-title":"Tumour heterogeneity and cancer cell plasticity","volume":"501","author":"Meacham","year":"2013","journal-title":"Nature"},{"key":"2022061706035193600_bib3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"2022061706035193600_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"2022061706035193600_bib5","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"2022061706035193600_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process","volume":"6","author":"Merlo","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2022061706035193600_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12628","article-title":"Selection and adaptation during metastatic cancer progression","volume":"501","author":"Klein","year":"2013","journal-title":"Nature"},{"key":"2022061706035193600_bib8","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"2022061706035193600_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"2022061706035193600_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31802b3488","article-title":"Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma","volume":"31","author":"Katona","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2022061706035193600_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/CMR.0b013e32833b7c7c","article-title":"Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns","volume":"20","author":"Harbst","year":"2010","journal-title":"Melanoma Res"},{"key":"2022061706035193600_bib12","doi-asserted-by":"crossref","first-page":"e29336","DOI":"10.1371\/journal.pone.0029336","article-title":"Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma","volume":"7","author":"Yancovitz","year":"2012","journal-title":"PLoS One"},{"key":"2022061706035193600_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"2022061706035193600_bib14","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"2022061706035193600_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma","volume":"18","author":"Middleton","year":"2000","journal-title":"J Clin Oncol"},{"key":"2022061706035193600_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet"},{"key":"2022061706035193600_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/aqw115","article-title":"Heterogeneity of metastatic melanoma","volume":"146","author":"Zand","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"2022061706035193600_bib18","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-15-3476","article-title":"Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma","volume":"76","author":"Harbst","year":"2016","journal-title":"Cancer Res"},{"key":"2022061706035193600_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1158\/0008-5472.CAN-07-1939","article-title":"Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis","volume":"68","author":"Sabatino","year":"2008","journal-title":"Cancer Res"},{"key":"2022061706035193600_bib20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<492::AID-IJC8>3.0.CO;2-#","article-title":"Clonal heterogeneity in sporadic melanomas as revealed by loss-of- heterozygosity analysis","volume":"85","author":"Takata","year":"2000","journal-title":"Int J Cancer"},{"key":"2022061706035193600_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamadermatol.2014.3689","article-title":"BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastases","volume":"151","author":"Eriksson","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2022061706035193600_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aaf2403","article-title":"Visualization and analysis of gene expression in tissue sections by spatial transcriptomics","volume":"353","author":"Stahl","year":"2016","journal-title":"Science"},{"key":"2022061706035193600_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"2022061706035193600_bib24","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1158\/1078-0432.CCR-04-1731","article-title":"Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival","volume":"11","author":"Grafstr\u00f6m","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061706035193600_bib25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00262-008-0631-1","article-title":"Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma","volume":"58","author":"Johansson","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"2022061706035193600_bib26","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"2022061706035193600_bib27","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/bioinformatics\/btx211","article-title":"ST Pipeline: an automated pipeline for spatial mapping of unique transcripts","volume":"33","author":"Navarro","year":"2017","journal-title":"Bioinformatics"},{"key":"2022061706035193600_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot: Elegant graphics for data analysis","author":"Wickham","year":"2009"},{"key":"2022061706035193600_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2022061706035193600_bib30","first-page":"1","article-title":"Package \u2018pheatmap\u2019","author":"Kolde","year":"2012","journal-title":"Bioconductor"},{"key":"2022061706035193600_bib31","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/s41467-018-04724-5","article-title":"Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity","volume":"9","author":"Berglund","year":"2018","journal-title":"Nat Commun"},{"key":"2022061706035193600_bib32","first-page":"2122","article-title":"A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor","volume":"5","author":"Lun","year":"2016","journal-title":"F1000Research"},{"key":"2022061706035193600_bib33","first-page":"267","article-title":"Visualizing data using t-SNE","volume":"620","author":"Van Der Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"key":"2022061706035193600_bib34","first-page":"42","article-title":"Novel platforms of multiplexed immunofluorescence for study of paraffin tumor tissues","volume":"2","author":"Parra","year":"2018","journal-title":"J Cancer Treat Diagnosis"},{"key":"2022061706035193600_bib35","article-title":"Deep profiling of mouse splenic architecture with CODEX multiplexed imaging","author":"Goltsev","year":"2018","journal-title":"bioRxiv"},{"key":"2022061706035193600_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cyto.a.23053","article-title":"Imaging mass cytometry","volume":"91","author":"Chang","year":"2017","journal-title":"Cytometry A"},{"key":"2022061706035193600_bib37","article-title":"Highly multiplexed analysis of immune cell subsets in non-small cell lung cancer: validation of protein and RNA analysis by the Nanostring Digital Spatial Profiling (DSP) platform","volume":"59","author":"Ziai","year":"2018","journal-title":"Proc Am Assoc Ca Res"},{"key":"2022061706035193600_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.2910620523","article-title":"Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491)","volume":"62","author":"Radford","year":"1995","journal-title":"Int J Cancer"},{"key":"2022061706035193600_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fonc.2015.00031","article-title":"Phenotype switching in melanoma: implications for progression and therapy","volume":"5","author":"Li","year":"2015","journal-title":"Front Oncol"},{"key":"2022061706035193600_bib40","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/0008-5472.CAN-14-1174","article-title":"Phenotype switching: Tumor cell plasticity as a resistance mechanism and target for therapy","volume":"74","author":"Kemper","year":"2014","journal-title":"Cancer Res"},{"key":"2022061706035193600_bib41","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/2159-8290.CD-13-0424","article-title":"A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors","volume":"4","author":"Konieczkowski","year":"2014","journal-title":"Cancer Discov"},{"key":"2022061706035193600_bib42","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1158\/1078-0432.CCR-15-2226","article-title":"Inflammatory marker testing identifies CD74 expression in melanoma tumor cells, and its expression associates with favorable survival for stage III melanoma","volume":"22","author":"Ekmekcioglu","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2022061706035193600_bib43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/gcc.22468","article-title":"Mutation patterns in genes encoding interferon signaling and antigen presentation: a pan-cancer survey with implications for the use of immune checkpoint inhibitors","volume":"56","author":"Budczies","year":"2017","journal-title":"Genes Chromosom Cancer"},{"key":"2022061706035193600_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"2022061706035193600_bib45","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","article-title":"MHC-I genotype restricts the oncogenic mutational landscape","volume":"171","author":"Marty","year":"2017","journal-title":"Cell"},{"key":"2022061706035193600_bib46","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"2022061706035193600_bib47","doi-asserted-by":"crossref","first-page":"e0149361","DOI":"10.1371\/journal.pone.0149361","article-title":"Expression of ferritin light chain (FTL) is elevated in glioblastoma, and FTL silencing inhibits glioblastoma cell proliferation via the GADD45\/JNK pathway","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"2022061706035193600_bib48","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1158\/1078-0432.CCR-14-0567","article-title":"Genetic evolution of T-cell resistance in the course of melanoma progression","volume":"20","author":"Sucker","year":"2014","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/78\/20\/5970\/2772586\/5970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/78\/20\/5970\/2772586\/5970.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T17:10:45Z","timestamp":1655485845000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/78\/20\/5970\/631815\/Spatially-Resolved-Transcriptomics-Enables"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":48,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2018,10,15]]},"published-print":{"date-parts":[[2018,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-18-0747","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]}}}